Table 2 Initial interviews: patient clinical characteristics according to disease condition

DISEASE INFORMATION: Duration of AF or last PE/DVT (years)

   Range

0.3 – 2.6

0.6 – 3

0.4 – 13

0.3 – 13

   Mean

1.3

1.2

5.8

3.1

TREATMENT INFORMATION

Name(s) of anticoagulation treatment(s)

   Previscan

1

1

3

5

   Coumadine

5

5

6

16

   Fenprocoumon

.

.

1

1

   Fraxodi

.

1

.

1

   Sintrom

.

.

1

1

   Marcoumar

2

1

2

5

   Acenocoumarol

1

1

.

2

Current anticoagulant administration route

   Oral

9

8

13

30

   Injection

.

1

.

1

Experience of anticoagulant self-injections

   Yes

3

3

2

8

   No

6

6

11

23

Blood test frequency

   Every 1 – 2 weeks

5

5

3

13

   Every 2 – 4 weeks

2

2

3

7

   Every month

2

2

4

8

   Every 1–2 months

.

.

3

3

Receiving an anticoagulant treatment since (year)

   Range

0.3 – 2

0.6 – 8

0.5 – 13

0.3 – 13

   Mean

1.2

2.3

5.6

3.3

Duration of anticoagulant treatment

   Lifetime

2

5

12

19

   One year

.

2

.

2

   6 months

3

1

1

5

   Less than 6 months

1

1

.

2

   Unknown

2

.

.

2

   Finished

1

.

.

1

OTHER CO-MORBIDITIES

   Yes

4

5

8

17

   No

5

4

5

14